Skip to main content

Advertisement

Table 1 Data sources, population type, summary statistics for overall QOL

From: Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Patient category N Mean Median Minimum Maximum Standard deviation
Advanced cancer 120 7.26 8.10 0.20 9.70 2.31
Brain cancer 26 6.46 7.00 2.00 9.00 1.88
Breast cancer 296 7.77 8.20 1.40 10.00 1.84
Lung cancer 1155 7.25 7.80 0.00 10.00 2.10
Colon cancer −2 Wks Post Surgery (Colectomy) 388 7.57 8.00 1.50 10.00 1.80
Colon cancer-Pre Surgery (Colectomy) 403 8.06 8.50 2.00 10.00 1.75
GI cancer 2409 7.74 8.30 0.00 10.00 1.86
GU cancer 180 8.29 9.00 2.40 10.00 1.61
Gynecologic cancer 117 7.83 8.20 1.80 10.00 1.75
Head and neck cancer 254 7.24 7.80 0.00 10.00 2.27
Hematologic cancer 32 7.33 7.70 1.70 9.30 2.03
Lymphatic cancer 8 7.21 8.45 3.20 9.20 2.51
Multiple site cancer 14 8.02 8.00 6.00 10.00 1.56
Musculoskeletal site cancer 18 6.68 7.55 1.80 10.00 2.78
Neurologic cancer 214 7.42 8.00 1.00 10.00 1.90
Other cancer 52 7.91 8.80 1.00 10.00 2.34
Lung cancer- Mayo study 529 7.03 7.00 0.00 10.00 2.18
Lung cancer - Mayo study 6 months post diagnosis 1409 7.05 7.60 0.00 10.00 2.40
Skin cancer 7 7.59 7.90 5.90 9.40 1.17
Unknown site cancer 29 6.60 7.00 2.10 10.00 2.25
Healthy NCCTG volunteers 54 8.31 9.00 5.00 10.00 1.19
Hospice caregivers 53 7.44 7.50 3.75 10.00 1.74
Hospice 52 5.89 5.75 2.00 9.75 2.03
Minnesota medical students 543 7.16 7.00 1.00 10.00 1.76
Mayo physicians 460 7.30 7.00 1.00 10.00 1.69
Mayo residents 295 6.46 7.00 1.00 10.00 1.91
  1. GI, gastroenterological; GU, genitourinary; NCCTG, North central chapter treatment group.
  2. Distributions for the various cohorts of Table 1 are displayed in Figures 2 and 3.